Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.

International Journal of Clinical Practice
M AboudBarry S Peters

Abstract

The aim of this study is to determine the cardiovascular disease (CVD) risk profile of a large UK HIV cohort and how highly active antiretroviral therapy (HAART) affects this. It is a cross-sectional study within a large inner city hospital and neighbouring district hospital. A total of 1021 HIV positive outpatients representative of the complete cohort and 990 who had no previous CVD were included in CVD risk analysis. We recorded demographics, HAART history and CVD risk factors. CVD and coronary heart disease (CHD) risks were calculated using the Framingham (1991) algorithm adjusted for family history. The non-CVD cohort (n = 990) was 74% men, 51% Caucasian and 73.1% were on HAART. Mean age was 41 +/- 9 years, systolic blood pressure 120 +/- 14 mmHg, total cholesterol 4.70 +/- 1.05 mmol/l, high-density lipoprotein-C 1.32 +/- 0.48 mmol/l and 37% smoked. Median CVD risk was 4 (0-56) % in men and 1.4 (0-37) % in women; CHD risks were 3.5 (0-36) % and 0.6 (0-16) %. CVD risk was > 20% in 6% of men and 1% of women and > 10% in 12% of men and 4% of women. CVD risk was higher in Caucasians than other ethnicities; the risk factor contributing most was raised cholesterol. For patients on their first HAART, increased CHD risk (26.2% vs....Continue Reading

References

Jan 1, 1991·American Heart Journal·K M AndersonW B Kannel
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P DubéUNKNOWN Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
Sep 10, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith S Currier
Feb 21, 2003·The New England Journal of Medicine·Samuel A BozzetteThomas A Louis
Jun 6, 2003·European Heart Journal·R M ConroyUNKNOWN SCORE project group
Nov 25, 2003·The New England Journal of Medicine·Nina Friis-MøllerUNKNOWN Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
Aug 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B M BergersenS Tonstad
Nov 26, 2005·Current Medical Research and Opinion·Ranjababu KulasekaramAnthony S Wierzbicki
Dec 21, 2005·Heart·UNKNOWN British Cardiac SocietyUNKNOWN Stroke Association
Feb 23, 2007·International Journal of Clinical Practice·M AboudB Peters
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Aug 19, 2007·Scandinavian Journal of Infectious Diseases·Giuseppe Vittorio L De SocioGiuseppe Schillaci
Jan 23, 2008·Current Medical Research and Opinion·Anthony S WierzbickiBarry S Peters
Apr 26, 2008·The Journal of Infection·Giuseppe Vittorio L De SocioUNKNOWN CISAI study group
Jun 25, 2008·BMJ : British Medical Journal·Julia Hippisley-CoxPeter Brindle
Sep 17, 2008·International Journal of Clinical Practice·H A W NeilP N Durrington
Apr 18, 2009·Current Opinion in HIV and AIDS·Judith S Currier, Jens D Lundgren
Jul 3, 2009·International Journal of Clinical Practice·A S Wierzbicki, T M Reynolds
Oct 30, 2009·Expert Opinion on Drug Metabolism & Toxicology·Danièle Bentué-FerrerEric Bellissant
Jan 1, 2008·Journal of Pain & Palliative Care Pharmacotherapy· National Quality Measures Clearinghouse, Agency For Healthcare Research And Quality

❮ Previous
Next ❯

Citations

Jul 20, 2011·AIDS Care·Jordan E LakeJudith S Currier
Jul 27, 2010·International Journal of Clinical Practice·S Das
May 30, 2013·Indian Journal of Pharmacology·Zahoor A RatherFaheem Mubeen
Dec 3, 2014·International Journal of Cardiology·Peter McKavanaghOnyekwelu Nzewi
May 4, 2012·Enfermedades infecciosas y microbiología clínica·Mar MasiáUNKNOWN Grupo de estudio de riesgo cardiovascular de CoRIS
Dec 8, 2015·The American Journal of Cardiology·Matthew J FeinsteinDonald M Lloyd-Jones
Aug 5, 2015·International Journal of Cardiology·Chidozie NdukaSaverio Stranges
Dec 18, 2012·International Journal of Clinical Practice·L KakinamiS G Fisher
Oct 16, 2016·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Matthew J FeinsteinDonald M Lloyd-Jones
Dec 22, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Andrea H WeinbergerJonathan Shuter
Mar 13, 2018·PloS One·Alastair D DuncanBarry S Peters
Apr 8, 2017·The Cochrane Database of Systematic Reviews·Cathy PayneSuzanne Martin
Aug 8, 2013·Journal of Cardiovascular Pharmacology·Yukiona Y T YeungSusan W S Leung
Nov 20, 2016·International Journal of Clinical Pharmacy·Elza Aparecida Machado DominguesMiguel Ángel Calleja-Hernández
Dec 14, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Stacy D FisherSteven E Lipshultz
Feb 9, 2021·Journal of Diabetes and Metabolic Disorders·Minyahil WolduEphrem Engidawork

❮ Previous
Next ❯

Software Mentioned

QRESEARCH
CREATE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.